This inventor holds 1 USPTO granted patent. Top assignee: Rnl Bio Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations in Colon Cancer Diagnosis by Myeong-Jin Nam
Introduction: Myeong-Jin Nam is an accomplished inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of colon cancer. His innovative approach focuses on utilizing specific antigens to improve diagnostic accuracy and patient outcomes.
Latest Patents: Myeong-Jin Nam holds a patent for a method for diagnosing colon cancer. This invention involves detecting a colon cancer-specific antigen, defensin α6, from the blood of patients. The diagnostic kit he developed includes anti-defensin α6 antibodies and various solid supports, such as ELISA plates and membranes, to facilitate the detection of this antigen. This method allows for the diagnosis of colon cancer using a minimal amount of blood, making the process easier and more accessible for patients.
Career Highlights: Myeong-Jin Nam is associated with RNL Bio Co., Ltd., where he continues to work on innovative solutions in the field of medical diagnostics. His dedication to research and development has positioned him as a key figure in advancing cancer detection technologies.
Collaborations:
Conclusion: Myeong-Jin Nam's contributions to colon cancer diagnosis exemplify the impact of innovation in healthcare. His work not only enhances diagnostic capabilities but also aims to improve patient care through early detection methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile